Tilmovet® 90 is a Type A Medicated Article for use in Swine and Cattle Feeds.
For the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. For the control of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group.
Do not allow horses or other equines access to feeds containing tilmicosin.
Swine: Feed containing tilmicosin shall not be fed to pigs for more than 21 days during each phase of production without ceasing administration for re-evaluation of antimicrobial use by a licensed veterinarian before re-initiating a further course of therapy with an appropriate antimicrobial. Veterinary Feed Directive (VFD) expiration date must not exceed ninety (90) days from the time of issuance. VFDs for tilmicosin phosphate shall not be refilled.
Cattle: Use only in cattle fed in confinement for slaughter. To assure both food safety and responsible use in cattle, the treatment of cattle with this medicated feed is required to be initiated within the first 45 days of the production period. The treatment should not occur concurrent with or following administration of an injectable macrolide, or within 3 days following administration of non-macrolide injectable BRD therapy. Tilmicosin medicated feed treatment has not been evaluated in cattle with severe clinical disease. Cattle with severe clinical illness should be evaluated for individual treatment with an alternative non-macrolide therapy. The expiration date for a tilmicosin Veterinary Feed Directive (VFD) for cattle must not exceed 45 days from the time of issuance. VFDs for tilmicosin phosphate shall not be refilled.
RESIDUE WARNING: Swine intended for human consumption must not be slaughtered within 7 days of the last treatment with this drug product.
RESIDUE WARNING: Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment with this drug product. This drug product is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. This drug product is not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves.The safety of tilmicosin has not been established in male swine or cattle intended for breeding purposes.
Avoid inhalation, oral exposure, and direct contact with skin or eyes. Operators mixing and handling Tilmovet should use protective clothing, impervious gloves, goggles, and a NIOSH-approved dust mask. Wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water. If irritation persists, seek medical attention.
NOT FOR HUMAN CONSUMPTION. KEEP OUT OF REACH OF CHILDREN.
For use in Swine and Cattle Feeds Only. Do not feed undiluted.
Restricted Drug (California) - Use only as directed.
See label for complete product directions.
Active Ingredient or Composition